SCPC’s Comment Letter on the Request for Information Regarding Reporting on Pharmacy Benefit and Prescription Drug Costs
Today, the Senior Care Pharmacy Coalition (SCPC) responded to questions on data collection impacting PBMs and prescription drug costs. First, SCPC urges the Biden Administration to define long-term care (LTC) pharmacies distinctly from other pharmacies (e.g., retail, mail order, and specialty). In addition, the coalition strongly recommends the new regulation collect information on rebates, fees, and other direct and indirect renumeration (DIR)—creating more transparency into the exchanges between key entities that drive up prescription drug costs. Namely, collecting data between health insurance plans, their Pharmacy Benefit Managers (PBMs), drug manufacturers, and pharmacies. Collecting and publicizing this information will support a broader investigation into the anti-competitive practices of major companies.
Read the full letter here.
Recent Posts
-
SCPC Calls for Immediate Congressional Action to Fix Broken LTC Pharmacy Payment Model as More Drugs Become Subject to Mandatory Medicare Price Negotiations
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
SCPC Praises FTC for Report Highlighting Egregious PBM Abuses; Encourages Congress and New Administration to Make PBM Reform an Immediate Priority in 2025
SCPC, the leading voice for the nation’s long-term care (LTC) pharmacy community, commends the FTC for once again shining a light on the abusive practices of the big PBMs that continue to rake in massive profits while patients, pharmacies, employers and taxpayers foot the bill for ever-increasing drug prices.
-
Seniors in Long-Term Care Could Lose Access to Essential LTC Pharmacy Services Absent Action from Congress
A new study from the Senior Care Pharmacy Coalition (SCPC), the nation’s leading voice for long-term care (LTC) pharmacies, performed by CLA (CliftonLarsonAllen LLP) and with input from ATI Advisory details the significant financial impact Medicare drug price negotiations will have on LTC pharmacies that provide essential, government required services to more than two million seniors and others in long-term care.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.